These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28017562)

  • 21. Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugates.
    Santora LC; Hobson AD; Wang L; Wu KX
    Anal Methods; 2024 Jun; 16(22):3492-3503. PubMed ID: 38770747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
    Gilroy JJ; Eakin CM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
    Källsten M; Pijnappel M; Hartmann R; Lehmann F; Kovac L; Lind SB; Bergquist J
    Anal Bioanal Chem; 2019 May; 411(12):2569-2576. PubMed ID: 30848315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native Reversed-Phase Liquid Chromatography: A Technique for LCMS of Intact Antibody-Drug Conjugates.
    Chen TH; Yang Y; Zhang Z; Fu C; Zhang Q; Williams JD; Wirth MJ
    Anal Chem; 2019 Feb; 91(4):2805-2812. PubMed ID: 30661356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatoraphy, part 2: Optimization of the phase system.
    Cusumano A; Guillarme D; Beck A; Fekete S
    J Pharm Biomed Anal; 2016 Mar; 121():161-173. PubMed ID: 26808065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future.
    Beck A; D'Atri V; Ehkirch A; Fekete S; Hernandez-Alba O; Gahoual R; Leize-Wagner E; François Y; Guillarme D; Cianférani S
    Expert Rev Proteomics; 2019 Apr; 16(4):337-362. PubMed ID: 30706723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of organic modifier and temperature on protein denaturation in hydrophobic interaction chromatography.
    Bobaly B; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2016 Nov; 131():124-132. PubMed ID: 27589029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates.
    Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S
    Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
    Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
    Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic approach to the method development of intact protein separations using hydrophobic interaction chromatography.
    Tyteca E; De Vos J; Tassi M; Cook K; Liu X; Kaal E; Eeltink S
    J Sep Sci; 2018 Mar; 41(5):1017-1024. PubMed ID: 29178450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability assessment of Polatuzumab vedotin and Brentuximab vedotin using different analytical techniques.
    Mohamed HE; Al-Ghobashy MA; Abbas SS; Boltia SA
    J Pharm Biomed Anal; 2023 May; 228():115249. PubMed ID: 36827859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advancing HIC method development: Retention-time modeling and tuning selectivity with ternary mobile-phase systems.
    Ewonde Ewonde R; Molenaar SRA; Broeckhoven K; Eeltink S
    J Chromatogr A; 2024 Aug; 1730():465133. PubMed ID: 38996515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method to directly analyze free-drug-related species in antibody-drug conjugates without sample preparation.
    de Mel N; Mulagapati SHR; Cao M; Liu D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1116():51-59. PubMed ID: 30981182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
    Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
    Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
    Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of low recovery in the free drug assay for antibody drug conjugates by size exclusion-reversed phase two dimensional-liquid chromatography.
    Li Y; Stella C; Zheng L; Bechtel C; Gruenhagen J; Jacobson F; Medley CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():112-118. PubMed ID: 27212187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the Primary Structure of Cysteine-Linked Antibody-Drug Conjugates Using Capillary Electrophoresis with Mass Spectrometry.
    Saadé J; Gahoual R; Beck A; Leize-Wagner E; François YN
    Methods Mol Biol; 2020; 2078():263-272. PubMed ID: 31643063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques.
    Chen T; Chen Y; Stella C; Medley CD; Gruenhagen JA; Zhang K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():39-50. PubMed ID: 27451254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis.
    Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increment in Drug Loading on an Antibody-Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro.
    Brachet G; Respaud R; Arnoult C; Henriquet C; Dhommée C; Viaud-Massuard MC; Heuze-Vourc'h N; Joubert N; Pugnière M; Gouilleux-Gruart V
    Mol Pharm; 2016 Apr; 13(4):1405-12. PubMed ID: 26900766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.